List view / Grid view
15 February 2019 | By European Pharmaceutical Review
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy, with enzalutamide...
15 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
14 February 2019 | By European Pharmaceutical Review
Draft guidance has been released to offer advice on the new CDER program for the recognition of voluntary consensus standards relating to pharma quality...
13 February 2019 | By European Pharmaceutical Review
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
13 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
12 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...
12 February 2019 | By European Pharmaceutical Review
Health Canada has issued a Notice of Compliance with conditions for the first oral drug for acute myeloid leukaemia, a rapidly progressing condition...
11 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The falsified medicines directive (FMD) has finally kicked in, but how will the UK supply chain be affected, and how will pharmacies and hospitals cope?
11 February 2019 | By European Pharmaceutical Review
Researchers have identified a method of improving the performance of infrared imaging techniques which could be useful in medical applications...
8 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
NICE in the UK and its counterpart - the Canadian Agency for Drugs and Technology in Health have collaborated to offer parallel scientific advice...
8 February 2019 | By European Pharmaceutical Review
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
8 February 2019 | By Pharmapack Europe
Innovations across drug delivery devices, dosage packaging, and materials and components bestowed in the Exhibitor Innovation Category...
7 February 2019 | By Nikki Withers (European Pharmaceutical Review)
Findings of two phase III, double-blind, randomised clinical trials comparing omadacycline with standard antibiotics have been published in the New England Journal of Medicine
7 February 2019 | By European Pharmaceutical Review
A combination therapy using the blood thinner cilostazol, along with either aspirin or clopidogrel, was shown to decrease the risk of stroke recurrence...
Follow: